Basic info
Industry
biotechnology research
Sectors
T-Cell exhaustion
Biotechnology
Health Care
Therapeutics
Medical
immunobiologics
immunooncology
Date founded
2020
Funding rounds raised
Total raised
$18M
from 3 investors over 3 rounds
E
EvolveImmune Therapeutics raised $18M on January 8, 2020
Investors: Elm Street Ventures, Takeda UK Limited and Solasta Ventures